Inventiva Bolsters Its Leadership with Three Key Hires Ahead of Crucial Results
Inventiva announced on Wednesday the recruitment of three new members to its executive team: Axel-Sven Malkomes as Chief Financial Officer, Susan Coles as Legal Director, and Pamela Herbster as Human Resources Director. These appointments come as the company prepares for the Phase 3 results of lanifibranor expected in the fourth quarter of 2026.
Experienced Professionals Join Inventiva
Axel-Sven Malkomes joins Inventiva as Chief Financial Officer, bringing over 30 years of experience in investment banking and corporate leadership. He recently held the CFO position at CureVac and has also served in this role at Cardior and Medigene. Susan Coles becomes Legal Director with more than 25 years of experience in supporting life sciences companies. She previously held this position at Inventiva from 2012 to 2014 and from 2019 to 2021, notably during the company's Nasdaq IPO. Pamela Herbster takes on the role of Human Resources Director with over 25 years of experience in the biopharmaceutical industry, including stints at Sage Therapeutics and Biogen.
Continued Roles and New Responsibilities
Jean Volatier, who served as Chief Financial Officer and has been with Inventiva since its inception, will take on the role of Executive Vice President of Finance and Corporate Social Responsibility. Nathalie Harroy, who was in charge of Human Resources, will remain at Inventiva and continue her contribution to the organization by leveraging her experience.
